AbbVie Inc (MEX:ABBV)
MXN 4,245 +124 (+3.01%) Market Cap: 7.57 Tn Enterprise Value: 8.69 Tn PE Ratio: 119.77 PB Ratio: 0 GF Score: 72/100

AbbVie Inc at Goldman Sachs Healthcare Conference Transcript

Jun 09, 2026 / 02:40PM GMT
Release Date Price: MXN3921.5 (+0.40%)
Unidentified Participant

All right. We're just about at time. So we can kick off our next session with AbbVie. Very excited to have the whole AbbVie management team over here with us, Rob Michael, CEO; Scott Reents, CFO and Roopal Thakkar, CSO. Thank you all for being with us today.

Robert Michael
AbbVie Inc - Chairman of the Board, Chief Executive Officer

Great to be with you.

Questions & Answers

Unidentified Participant

So Rob, maybe starting with you with a big picture question. Just to sort of like high level, frame for us for AbbVie today as we look out to the next 5 to 10 years, how do you expect the complexion of the company to evolve with respect to therapeutic areas, business lines and potential new pillars of growth?

Robert Michael
AbbVie Inc - Chairman of the Board, Chief Executive Officer

Like I think what you're seeing is a continuation of the strategy where we've talked about a quick return to growth. We hit our peak sales last year, just two years after the US

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot